Berkshire Capital Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10
Closed -$7.79K 120
2025
Q2
$7.79K Hold
10
﹤0.01% 30
2025
Q1
$8.26K Hold
10
﹤0.01% 23
2024
Q4
$7.72K Hold
10
﹤0.01% 27
2024
Q3
$8.86K Sell
10
-16,480
-100% -$14.8M ﹤0.01% 24
2024
Q2
$14.9M Buy
16,490
+16,480
+164,800% +$13.2M 6.04% 5
2024
Q1
$7.78K Buy
+10
New +$7.12K ﹤0.01% 24

Other funds holding LLY

Berkshire Capital Holdings's LLY Position: Q3 2025 in Review

Berkshire Capital Holdings sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 10 shares — an estimated $7.79K sold.

Berkshire Capital Holdings first reported a position in LLY in Q1 2024 and held it in 6 quarters. The position peaked at $14.9M in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Berkshire Capital Holdings reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Berkshire Capital Holdings sold 10 Eli Lilly shares in Q3 2025, an estimated $7.79K.
  • Berkshire Capital Holdings first reported a position in Eli Lilly in Q1 2024 and held it in 6 quarters.
  • Berkshire Capital Holdings's Eli Lilly position peaked at $14.9M in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Berkshire Capital Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.